You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
McKinsey
McKesson
Mallinckrodt
Harvard Business School

Last Updated: February 16, 2020

DrugPatentWatch Database Preview

CIMZIA Drug Profile


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Summary for Tradename: CIMZIA
Patents:76
Applicants:1
BLAs:1
Suppliers: see list1
Drug Prices: Drug price information for CIMZIA
Recent Clinical Trials: See clinical trials for CIMZIA
Drug Prices for CIMZIA

See drug prices for CIMZIA

Recent Clinical Trials for CIMZIA

Identify potential brand extensions & biosimilar entrants

SponsorPhase
UCB Biopharma S.P.R.L.Phase 1
University of California, San FranciscoPhase 1
UCB Biopharma S.P.R.L.Phase 3

See all CIMZIA clinical trials

Pharmacology for CIMZIA
Mechanism of ActionTumor Necrosis Factor Receptor Blocking Activity

Patent Text Search: US Patents for CIMZIA

These patents were identified by searching patent claims
Glossary
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Ucb Inc CIMZIA certolizumab pegol INJECTABLE; INJECTION 125160 001 2008-04-22   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2033-03-11 RX search
Ucb Inc CIMZIA certolizumab pegol INJECTABLE; INJECTION 125160 001 2008-04-22   Start Trial Knopp Biosciences LLC (Pittsburgh, PA) 2033-08-13 RX search
Ucb Inc CIMZIA certolizumab pegol INJECTABLE; INJECTION 125160 001 2008-04-22   Start Trial Agency for Science, Technology and Research (Singapore, SG) 2033-02-13 RX search
Ucb Inc CIMZIA certolizumab pegol INJECTABLE; INJECTION 125160 001 2008-04-22   Start Trial Nestec S.A. (Vevey, CH) 2031-05-10 RX search
Ucb Inc CIMZIA certolizumab pegol INJECTABLE; INJECTION 125160 001 2008-04-22   Start Trial CureVac AG (Tubingen, DE) 2032-02-15 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Harvard Business School
McKinsey
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
Copyright 2002-2020 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2020 - 2021
 NCE-1 Patent Challenge Dates 2020 - 2021
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2020, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group

DrugPatentWatch reviews